OR WAIT null SECS
© 2022 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
August 09, 2022
Alzheimer disease psychosis treatment pimavanserin receives Complete Response Letter from the FDA.
July 28, 2022
Is our research about Alzheimer disease wrong?
July 19, 2022
Study shows promising results for early detection and prevention efforts.
May 03, 2022
Top-line data for study is expected in late 2022, early 2023.
Compelling new book discusses love, Alzheimer disease, and medical aid in dying.
April 06, 2022
Individuals with depression may be at a greater risk to develop late-onset Alzheimer disease, but a new study suggests depression onset may help predict Alzheimer disease.
March 24, 2022
How can you communicate the diagnosis in a way that relieves suffering and helps patients and their caregivers prepare for the future?
March 23, 2022
This donepezil transdermal system helps with the treatment on mild, moderate, or severe dementia of the Alzheimer type.
March 22, 2022
Research also finds surprising results in patients with bipolar affective disorder.
November 29, 2021
The American Academy of Neurology issued a position statement for mental health professionals, warning them to carefully discuss the benefits and known harms of aducanumab.